Group One Trading
AMRX icon

Group One Trading’s Amneal Pharmaceuticals AMRX Stock Holding History

Group One Trading’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,991
Closed -$26.8K – 8336
2025
Q2 		$24.2K Sell
2,991
-202
-6% -$1.52K ﹤0.01% 6135
2025
Q1 		$26.8K Buy
3,193
+2,494
+357% +$20.8K ﹤0.01% 5620
2024
Q4 		$5.54K Buy
+699
New +$5.86K ﹤0.01% 6380
2023
Q3 		– Sell
-880
Closed -$3.28K – 7600
2023
Q2 		$2.73K Buy
+880
New +$1.88K ﹤0.01% 6979
2023
Q1 		– Sell
-35,532
Closed -$70.7K – 7147
2022
Q4 		$70.7K Sell
35,532
-385,477
-92% -$864K ﹤0.01% 4743
2022
Q3 		$850K Sell
421,009
-71,279
-14% -$200K ﹤0.01% 2737
2022
Q2 		$1.56M Buy
492,288
+372,128
+310% +$1.35M ﹤0.01% 2286
2022
Q1 		$501K Buy
120,160
+6,306
+6% +$27.9K ﹤0.01% 3811
2021
Q4 		$545K Buy
113,854
+78,102
+218% +$389K ﹤0.01% 4033
2021
Q3 		$191K Buy
35,752
+11,713
+49% +$59K ﹤0.01% 5223
2021
Q2 		$123K Sell
24,039
-1,095
-4% -$6.22K ﹤0.01% 5743
2021
Q1 		$169K Buy
+25,134
New +$139K ﹤0.01% 5191
2020
Q4 		– Sell
-3,836
Closed -$17K – 6434
2020
Q3 		$15K Buy
+3,836
New +$16.4K ﹤0.01% 5251
2020
Q2 		– Sell
-41,133
Closed -$169K – 5747
2020
Q1 		$143K Sell
41,133
-18,855
-31% -$79.9K ﹤0.01% 3012
2019
Q4 		$289K Buy
59,988
+21,237
+55% +$73.8K ﹤0.01% 2894
2019
Q3 		$112K Buy
38,751
+37,300
+2,571% +$130K ﹤0.01% 3481
2019
Q2 		$10K Buy
+1,451
New +$14.8K ﹤0.01% 4410
2018
Q4 		– Sell
-34,090
Closed -$756K – 4823
2018
Q3 		$756K Sell
34,090
-17,600
-34% -$370K 0.01% 1923
2018
Q2 		$848K Buy
+51,690
New +$907K 0.01% 1865

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Group One Trading's AMRX Position: Q3 2025 in Review

Group One Trading sold out of Amneal Pharmaceuticals (AMRX) in Q3 2025, closing a stake of 2,991 shares — an estimated $26.8K sold.

Group One Trading first reported a position in AMRX in Q2 2018 and held it in 19 quarters. The position peaked at $1.56M in Q2 2022. 248 funds tracked by Wall St. Rank hold AMRX as of Q3 2025.

  • Group One Trading reported no remaining Amneal Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 2,991 Amneal Pharmaceuticals shares in Q3 2025, an estimated $26.8K.
  • Group One Trading first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 19 quarters.
  • Group One Trading's Amneal Pharmaceuticals position peaked at $1.56M in Q2 2022.
  • 248 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.